Decision to Issue Convertible Bonds with 5 Funds, Call and Put Options Detailed

Cytogen decided to issue convertible bonds to 5 institutional investors (Pharos Guardian KOSDAQ Venture General Private Investment Trust, Oreum KOSDAQ Venture General Private Investment Trust No. 2, Intrus KOSDAQ Venture General Private Investment Trust No. 2, Truston Tium Mezzanine General Private Investment Trust No. 3, NH Absolute Return General Private Investment Trust No. 1).
Bondholders can exercise a put option quarterly starting 18 months after issuance, receiving 100% of face value (early redemption yield 0.0% per annum).
The issuer can exercise a call option to purchase up to 30% of each holder's bonds quarterly from 12 months (May 26, 2027) to 18 months (Nov 26, 2027) after issuance, at a price calculated with 1.0% annual compound interest from the issue date (1st: 101.0%, 2nd: 101.2538%, 3rd: 101.5077%).
Investors have a tag-along right to participate in any sale by the major shareholder on the same terms.
The 6th series convertible bonds were acquired early on April 23, 2026, by agreement with the bondholder, with future handling to be decided by the board.

ADVERTISEMENT (250px+)